OpenJournalRank
Compare

Journal rankings · indicator year 2025

Choose a field to open its ranking, or a journal to find its row in its subfield’s list.

Subfield ranking · 2025

Epidemiology journal rankings 2025

178 ranked journals · Subfield in Medicine

Epidemiology has 178 ranked journals in 2025. The median journal has an OJR of 0.80, below the world average of 1.00, up 0.04 on 2024; Q1 starts at OJR 1.19. The two highest-scoring journals with stable ranks are ˜The œLancet. Gastroenterology & hepatology and Journal of Hepatology: each is likely ranked within the top 3.

Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.

Ranked journals

Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.

178
4% of Medicine
Median OJR

The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.

The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.

The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.

0.80+0.04 vs 2024
This subfieldAll 0.78World 1.00
Open-access journals

Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.

44%
All fields: 38%
Median listed APC

Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.

$3,190
Median positive listed APC: $3,190 among 91 journals. Another 2 list $0; 85 have no known price. All fields: $3,200.

Subfields of Medicine (42)

Show all 42 subfields

178 ranked journals

Filters

Quartile

Quartiles split the ranked journals of the list you are viewing into four equal groups by OJR. Q1 is the top quarter and Q4 the bottom quarter.

They are computed within the list on screen, so a journal can be Q1 in its subfield and Q2 in the global ranking.

Access
APC (list price)
Loading every ranked journal in this list…
Epidemiology ranking, 2025

Rank is the position by OJR within the list on screen; 1 is the highest.

The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different.

OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields.

The badge is the journal’s quartile in this list.

OJR

Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field.

▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor.

Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked.

Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal.

List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed.

The line is the journal’s OJR from 2016 to 2025.

A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change.

Compare
Rank 1; likely between #1 and #3 of 178˜The œLancet. Gastroenterology & hepatologyElsevier BV · United Kingdom
6.09Q115.18 2.28 down from 202454634%$7,280Rising vs field, 2022–25
Rank 2; likely between #1 and #3 of 178Journal of HepatologyElsevier BV · Denmark
5.88Q118.77 2.17 up from 20241,17210%$5,500
Rank 3; likely between #2 and #5 of 178AutophagyTaylor & Francis · United States
4.89Q116.03 3.40 up from 202449999%—
Rank 4; likely between #2 and #6 of 178MetabolismElsevier BV · United States
4.38Q116.10 3.92 up from 202442237%$5,340Rising vs field, 2022–25
Rank 5; likely between #3 and #6 of 178Nature Reviews Gastroenterology & HepatologyNature Portfolio · United Kingdom
4.35Q120.05 1.39 up from 202443217%—
Rank 6; likely between #5 and #10 of 178Clinical and Molecular HepatologyOAKorean Association for the Study of the Liver · South Korea
3.40Q19.23 3.83 down from 2024380100%$32Rising vs field, 2022–25
Rank 7; likely between #6 and #13 of 178eGastroenterologyOABMJ
2.98Q19.09 5.52 up from 202453100%—
Rank 8; likely between #3 and #18 of 178International Journal of StrokeSAGE Publishing · United Kingdom
2.96Q18.14 1.32 down from 202435752%$4,400
Rank 9; likely between #6 and #11 of 178StrokeLippincott Williams & Wilkins · United States
2.91Q19.08 1.20 up from 20241,23312%—Rising vs field, 2022–25
Rank 10; likely between #7 and #12 of 178Clinical Gastroenterology and HepatologyElsevier BV · United States
2.72Q18.55 1.37 up from 20241,18739%$4,470Rising vs field, 2022–25
Rank 11; likely between #4 and #57 of 178Tumour Virus ResearchOAElsevier BV · Netherlands
2.44Q14.06 6.55 down from 202460100%$3,110
Rank 12; likely between #10 and #14 of 178The Lancet Regional Health - Western PacificOAElsevier BV · United Kingdom
2.32Q16.36 0.16 up from 2024797100%$4,250
Rank 13; likely between #9 and #23 of 178Journal of StrokeOASouth Korea
2.21Q17.90 1.16 up from 2024152100%—
Rank 14; likely between #9 and #26 of 178Journal of Intensive CareOABioMed Central · United Kingdom
2.07Q17.57 2.40 up from 2024170100%$2,577
Rank 15; likely between #13 and #22 of 178Hepatology CommunicationsOALippincott Williams & Wilkins · United States
1.85Q15.90 0.74 up from 2024761100%$2,700
Rank 16; likely between #12 and #28 of 178Infectious Disease Clinics of North AmericaElsevier BV · United States
1.84Q14.37 0.80 down from 202415311%$4,050
Rank 17; likely between #13 and #32 of 178Stroke and Vascular NeurologyOABMJ · China
1.78Q15.06 0.03 down from 2024243100%$1,839
Rank 18; likely between #14 and #25 of 178Alimentary Pharmacology & TherapeuticsWiley · United Kingdom
1.77Q15.22 0.10 down from 202490481%$5,250Rising vs field, 2022–25
Rank 19; likely between #10 and #59 of 178PneumoniaOABioMed Central · United Kingdom
1.75Q13.54 3.07 down from 202456100%$2,690
Rank 20; likely between #12 and #36 of 178Journal of NeuroendocrinologyWiley · United Kingdom
1.75Q15.67 0.90 up from 202434373%$4,550Rising vs field, 2022–25
Rank 21; likely between #13 and #32 of 178European Stroke JournalSAGE Publishing · United Kingdom
1.74Q15.47 0.49 up from 2024356100%$4,400
Rank 22; likely between #14 and #29 of 178AddictionWiley · United Kingdom
1.74Q15.24 0.55 up from 202471484%$4,600
Rank 23; likely between #16 and #34 of 178Current Opinion in Infectious DiseasesLippincott Williams & Wilkins · United States
1.64Q14.87 0.30 up from 202423425%—Rising vs field, 2022–25
Rank 24; likely between #17 and #31 of 178Harm Reduction JournalOABioMed Central · United Kingdom
1.63Q14.33 0.15 down from 2024531100%$3,290
Rank 25; likely between #20 and #33 of 178International Journal of Drug PolicyElsevier BV · Netherlands
1.56Q14.16 0.07 down from 202477674%$4,350
Rank 26; likely between #17 and #40 of 178Influenza and Other Respiratory VirusesOAWiley · United Kingdom
1.53Q13.75 0.40 down from 2024429100%$4,840
Rank 27; likely between #13 and #51 of 178Annals of HepatologyOAElsevier BV · Mexico
1.52Q15.04 0.24 down from 2024314100%$1,500Rising vs field, 2022–25
Rank 28; likely between #17 and #44 of 178Seminars in Liver DiseaseThieme Medical Publishers (Germany) · United States
1.51Q14.11 0.02 up from 202411333%—
Rank 29; likely between #18 and #41 of 178Clinical EpidemiologyOADove Medical Press · New Zealand
1.50Q13.95 0.49 up from 2024320100%$2,836
Rank 30; likely between #20 and #39 of 178Expert Review of VaccinesOAInforma · United States
1.49Q15.57 0.83 up from 2024303100%—
Rank 31; likely between #22 and #44 of 178Substance Abuse Treatment Prevention and PolicyOABioMed Central · United Kingdom
1.45Q13.68 0.27 up from 2024197100%$3,090
Rank 32; likely between #25 and #41 of 178Veterinary ResearchOABioMed Central · United Kingdom
1.43Q13.83 0.01 down from 2024401100%$2,390
Rank 33; likely between #20 and #50 of 178Addictive Behaviors ReportsOAElsevier BV · United Kingdom
1.40Q12.94 0.52 down from 2024163100%$3,330
Rank 34; likely between #16 and #61 of 178Contemporary Drug ProblemsSAGE Publishing · United States
1.39Q13.08no change7671%$3,400
Rank 35; likely between #25 and #44 of 178International Breastfeeding JournalOABioMed Central · United Kingdom
1.39Q14.01 0.16 up from 2024241100%$3,090Falling vs field, 2022–25
Rank 36; likely between #24 and #48 of 178Journal of Clinical and Translational HepatologyOAUnited States
1.39Q14.24 0.08 up from 2024375100%—Rising vs field, 2022–25
Rank 37; likely between #15 and #77 of 178Substance Abuse Research and TreatmentOASAGE Publishing · United States
1.34Q14.32 1.41 up from 2024109—$2,650
Rank 38; likely between #29 and #46 of 178Journal of NeurotraumaMary Ann Liebert, Inc. · United States
1.33Q13.97 0.17 up from 202456238%—
Rank 39; likely between #21 and #58 of 178˜The œItalian Journal of Pediatrics/Italian journal of pediatricsOABioMed Central · United Kingdom
1.31Q13.93 0.03 down from 2024622100%$2,790
Rank 40; likely between #34 and #44 of 178Journal of VirologyOAAmerican Society for Microbiology · United States
1.30Q14.17 0.23 up from 20241,708100%—
Rank 41; likely between #36 and #47 of 178VaccineElsevier BV · United Kingdom
1.26Q13.53 0.32 down from 20242,84467%$3,620
Rank 42; likely between #22 and #75 of 178Psychological Injury and LawSpringer Science+Business Media · United States
1.25Q13.42 0.69 up from 20248048%$3,290
Rank 43; likely between #24 and #68 of 178Journal of Multimorbidity and ComorbidityOASAGE Publishing · United Kingdom
1.24Q12.86 0.47 down from 202488100%$1,575
Rank 44; likely between #34 and #57 of 178Journal of Clinical VirologyElsevier BV · Netherlands
1.20Q13.89 0.35 up from 202432058%$4,210
Rank 45; likely between #39 and #54 of 178Journal of NeuroInterventional SurgeryBMJ · United Kingdom
1.19Q13.81 0.06 down from 202491832%—Falling vs field, 2022–25
Rank 46; likely between #35 and #60 of 178Psychology of Addictive BehaviorsAmerican Psychological Association · United States
1.18Q22.64no change23548%—
Rank 47; likely between #37 and #58 of 178MycosesWiley · Germany
1.17Q23.53 0.07 up from 202435667%$4,780
Rank 48; likely between #39 and #62 of 178Ophthalmic and Physiological OpticsWiley · United Kingdom
1.14Q23.44 0.89 up from 202445376%$4,050
Rank 49; likely between #29 and #80 of 178Liver ResearchOAElsevier BV · China
1.13Q24.22 1.94 up from 2024104100%$0 listed
Rank 50; likely between #39 and #70 of 178Jornal de PediatriaOAElsevier BV · Brazil
1.09Q23.18 0.68 up from 2024297100%$1,800

The endpoints below each rank show its likely range. How rank ranges are calculated

Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.

57 additional Epidemiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.

Rising journals

At a glance

Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated

Ranked journals
178
Window papers (baseline)
220,321 +3.6% from indicator year 2022
Median OJR
0.797 -1.9% from indicator year 2022
Rising journals (2025)
17

Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.

Category by indicator year
MeasureYear series20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
Ranked journals77818789949197108114119129139147157166176187185193198196204196199187178
Window papers (baseline)48,70154,88759,55464,14967,38374,61683,63394,079103,216113,942125,223136,221144,307149,052156,773162,831168,650170,014174,699179,855189,056200,238212,651217,205217,754220,321
Median OJR0.6680.610.6700.710.690.822230.850.82870.8350.860.82930.8300.870.8440.8360.7950.822240.8030.740.8320.780.7550.810.7870.7600.797

How to read these rankings

OJR, the OpenJournalRank Indicator
A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
Quartiles
Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
Impact factor (2-year)
Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
Rank ranges
Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.